Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
Jun. 30, 2024	Jun. 30, 2023
Operating expenses
Research and development expenses, net of government assistance	$ (2,708)	$ (1,095)
General and administrative expenses	(2,255)	(1,874)
Restructuring cost	0	(1,485)
Loss from operating activities	(4,963)	(4,454)
Foreign exchange (loss) gain	(8)	8
Change in fair value of derivative warrant liabilities	1,395	0
Interest income and other expense, net	235	134
Total other income, net	1,622	142
Loss before income tax recovery	(3,341)	(4,312)
Income tax benefit	724	289
Net loss and total comprehensive loss	$ (2,617)	$ (4,023)
Loss per share, Basic	$ (0.24)	$ (0.54)
Loss per share, Diluted	$ (0.24)	$ (0.54)
Weighted Average Number of Shares Outstanding, Basic	10,928,543	7,435,533
Weighted Average Number of Shares Outstanding, Diluted	10,928,543	7,435,533

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.